Improvement in serum eosinophilia is observed in clinical responders to ustekinumab but not adalimumab in inflammatory bowel disease - Quiz - MDSpire

Improvement in serum eosinophilia is observed in clinical responders to ustekinumab but not adalimumab in inflammatory bowel disease

  • By

  • Emily C L Wong

  • Parambir S Dulai

  • John K Marshall

  • Vipul Jairath

  • Walter Reinisch

  • Neeraj Narula

  • January 13, 2025

  • 0 min

Share

Original Source(s)

Improvement in serum eosinophilia is observed in clinical responders to ustekinumab but not adalimumab in inflammatory bowel disease

  • by Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula

  • January 13, 2025

Related Content

Integrating Double-Balloon Enteroscopy into the Diagnostic Pathway for Suspected Small Bowel Crohn’s Disease: A Retrospective Study from a Tertiary Care Center

The role of the complement system in gastrointestinal-related diseases

Rapunzel Syndrome Masks Weight Loss

Researchers identify an extensive trichobezoar in a child with progressive weight loss and feeding changes.